Νέα

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO^® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior T

Menarini Group: committed to fighting today's COVID-19 pandemic with an eye to averting similar health crises in the future

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

Menarini Group completes a solid year of operating performance

Menarini Group announced its 2019 results

Menarini Group Completes Acquisition of Stemline Therapeutics

Menarini Group today announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics (Nasdaq: STML), for an aggregate cash consideration up to $677 million on a fully diluted basis.

1 2 3 4